Moleculin Biotech's total assets for Q2 2026 were $21.09M, a decrease of -9.74% from the previous quarter. DE:MOL0 total liabilities were $9.50M for the fiscal quarter, a 16.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.